John B. Sanfilippo & Son, Inc. — Form 10-Q Summary
Period clarification: The request identifies 2020 Q3, but the supplied filing is for the quarter ended March 24, 2022 (fiscal 2022 Q3), compared primarily with March 25, 2021. Figures below are in U.S. dollars; financial statement amounts are in thousands unless stated otherwise.
Business context and reporting period
The company processes and distributes nuts and other snack and food products under its own brands and private labels. It sells through consumer, commercial ingredients, and contract packaging channels. The filing covers the quarter and first 39 weeks of fiscal 2022; fiscal 2022 is a 53-week year.
Financial performance and position
- Quarter: Net sales rose 5.1% to $218.6 million, while sales volume fell 2.8%. Higher average selling prices (up 8.1%) more than offset lower volume. Gross profit declined 14.4% to $39.4 million; gross margin fell to 18.0% from 22.1%. Operating income was $17.4 million versus $21.1 million, and net income was $11.9 million versus $14.7 million. Diluted EPS was $1.02 versus $1.27.
- First 39 weeks: Sales increased 7.1% to $698.1 million, with volume up 5.6%. Gross profit increased 3.8% to $143.4 million, but gross margin declined to 20.5% from 21.2%. Operating income decreased to $63.0 million from $67.8 million; net income was $44.4 million versus $47.4 million. Diluted EPS was $3.83 versus $4.10.
- Cash flow: Operating activities used $12.6 million, compared with $77.0 million provided a year earlier, mainly reflecting a $63.1 million inventory cash outflow. Investing activities used $6.5 million, including $12.8 million of capital spending. Financing activities provided $19.0 million, including $57.2 million of net revolving-credit borrowings and $34.5 million of dividends paid. Cash was $0.7 million at March 24, 2022.
- Liquidity and debt: Current assets were $288.2 million and current liabilities $145.8 million. Revolver borrowings were $65.9 million, with $47.4 million of availability under the $117.5 million facility, after letters of credit. Current and long-term debt totaled $11.9 million, excluding revolving borrowings. The company reported compliance with credit and mortgage covenants. The mortgage facility, with $3.4 million principal outstanding, matures March 1, 2023; the revolving facility matures March 5, 2025.
- Inventory and equity: Inventory was $211.1 million, up 42.7% from June 2021 and 39.1% year over year. Total liabilities were $198.8 million and stockholders’ equity was $254.8 million at quarter-end.
Material changes versus prior comparable periods
- Quarterly sales growth was price-led: volume declined, while inflation and commodity cost pass-through lifted average selling prices. Commercial ingredients and contract packaging grew, while consumer-channel volume decreased.
- Quarterly gross margin contracted materially due mainly to higher nut acquisition costs and inflation in labor, freight, and manufacturing supplies. Year-to-date gross profit rose, but margin also declined.
- Year-to-date selling expenses increased $12.0 million, including higher advertising and freight costs. Total operating expenses rose $10.0 million; quarterly expenses fell, partly because incentive compensation was lower.
- Year-to-date operating cash flow reversed from a $77.0 million inflow to a $12.6 million outflow, and revolving borrowings increased substantially, primarily to fund higher-cost inventory and procurement.
- Dividends were $3.00 per share during the first 39 weeks, compared with $2.50 per share in the prior-year period; total dividends paid were lower year over year.
Outlook, commentary, risks, and unusual items
- Management expects operating cash flow and available credit to fund operations for the next 12 months and expects fiscal 2022 capital expenditures of approximately $18 million.
- Management cited inflation, higher commodity costs, packaging and ingredient shortages, transportation delays, port congestion, labor constraints, and the war in Ukraine as pressures on costs, supply, and production efficiency. It expects some cost relief if shortages ease, but warned that costs may remain elevated or unpredictable and that passing increases to customers may be difficult.
- Management described competition, consumer trade-down and channel shifts, food safety, customer concentration and purchasing changes, inventory valuation, and possible facility disruptions as risks. It reported no significant changes to the risk factors in its latest 10-K.
- Unusual items included a $2.349 million gain on the sale of the Garysburg, North Carolina facility, and a $0.5 million gain from selling certain life insurance policies to members of the Sanfilippo family under a contractual purchase option. The company received approximately $4.0 million and $3.2 million, respectively, in proceeds.
- Management said ordinary-course legal proceedings were not expected to materially affect results, while noting adverse outcomes remain possible. Disclosure controls were reported effective, with no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Confirm the intended period: the supplied filing is fiscal 2022 Q3, not 2020 Q3.
- Track whether price increases can offset commodity, freight, labor, and packaging costs without further weakening sales volume or margins.
- Monitor inventory levels, operating cash conversion, and revolving borrowings as procurement costs and working-capital needs change.
- Review refinancing or repayment plans for the mortgage facility due March 2023 and ongoing covenant headroom.
- Assess the sustainability of dividends and planned capital spending alongside cash generation and debt usage.
- Monitor supply-chain disruptions, consumer trade-down, and the potential effect of legal or food-safety contingencies.